BioStock: BioInvent to present promising clinical data at ASCO and EHA

In the coming weeks, BioInvent is set to present three significant data sets at the American Society for Clinical Oncology’s (ASCO) annual congress and the European Hematology Association’s (EHA) annual meeting. At ASCO, BioInvent will showcase advancements with BI-1808 monotherapy and BI-1206 in combination with Keytruda. At EHA, promising data on BI-2106 will be presented to the expert community.

Read the article at biostock.se:

https://www.biostock.se/en/2024/05/bioinvent-to-present-promising-clinical-data-at-asco-and-eha/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/